Approval · Notice of Compliance 2193 · 2001
MYOCET: Notice of Compliance 2193
Issued December 21, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2193
- Date
- December 21, 2001
- Company
- The Liposome Company Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYOCET | 02245015 | Dormant |
Medicinal ingredients
- DOXORUBICIN HYDROCHLORIDE 2 MG per ML